Source: DGNews | Posted 8 years ago
FDA Grants Approvable Letter for Adult Adderall XR, for Management of Attention Deficit Hyperactivity Disorder
Tags:
ROCKVILLE, MD -- October 20, 2003 -- Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has received an 'approvable' letter from the US Food and Drug Administration (FDA) for Adderall XR
Comments